Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.68B | 9.95B | 8.80B | 6.35B | 4.74B |
Gross Profit | 4.62B | 4.20B | 3.49B | 1.36B | 414.93M |
EBITDA | 4.84B | 4.44B | 3.71B | 1.74B | 804.28M |
Net Income | 2.54B | 2.31B | 1.81B | 567.68M | 10.07M |
Balance Sheet | |||||
Total Assets | 26.29B | 22.86B | 21.61B | 20.44B | 20.44B |
Cash, Cash Equivalents and Short-Term Investments | 5.92B | 5.59B | 4.78B | 3.28B | 2.98B |
Total Debt | 10.58B | 9.52B | 10.22B | 11.47B | 12.59B |
Total Liabilities | 13.54B | 12.43B | 13.32B | 13.90B | 14.45B |
Stockholders Equity | 12.75B | 10.43B | 8.29B | 6.54B | 5.99B |
Cash Flow | |||||
Free Cash Flow | -524.97M | 1.58B | 2.62B | 1.55B | -2.08B |
Operating Cash Flow | 3.28B | 2.84B | 3.00B | 2.06B | -10.38M |
Investing Cash Flow | -3.78B | -1.16B | -194.43M | -516.12M | -2.07B |
Financing Cash Flow | 836.12M | -872.61M | -1.30B | -1.24B | 1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥22.48B | 8.30 | 1.29% | 10.08% | 15.90% | ||
76 Outperform | ¥32.65B | 6.38 | 1.49% | 21.18% | 8.81% | ||
72 Outperform | ¥19.53B | 7.31 | 1.23% | 20.01% | 290.10% | ||
70 Neutral | ¥7.75B | 9.39 | 0.47% | 3.63% | -7.07% | ||
67 Neutral | ¥277.48B | 14.88 | 6.81% | 2.50% | 5.07% | -22.68% | |
61 Neutral | ¥15.72B | 6.63 | 0.49% | 28.56% | 213.63% | ||
58 Neutral | ¥17.78B | 72.51 | 6.59% | ― | 17.45% | 664.98% |